Responses
Poster Presentations
Rheumatoid arthritis - other biologic treatment
SAT0209 Early Response to Tocilizumab (TCZ) and Benefit of Continued TCZ Treatment in Partial TCZ Responders: Results of the Mirai-Study
Compose a Response to This Article
Other responses
No responses have been published for this article.